title: [Guidelines on diagnosis and treatment of pulmonary arterial hypertension].
authors.affiliation: Institute of Cardiology, University of Bologna, Italy. n.galie@bo.nettuno.it
authors.forename: Nazzareno
authors.initials: N
authors.lastname: Galiè
authors.forename: Adam
authors.initials: A
authors.lastname: Torbicki
authors.forename: Robyn
authors.initials: R
authors.lastname: Barst
authors.forename: Philippe
authors.initials: P
authors.lastname: Dartevelle
authors.forename: Sheila
authors.initials: S
authors.lastname: Haworth
authors.forename: Tim
authors.initials: T
authors.lastname: Higenbottam
authors.forename: Horst
authors.initials: H
authors.lastname: Olschewski
authors.forename: Andrew
authors.initials: A
authors.lastname: Peacock
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Pietra
authors.forename: Lewis J
authors.initials: LJ
authors.lastname: Rubin
authors.forename: Gerald
authors.initials: G
authors.lastname: Simonneau
mesh_terms: D000465:Algorithms; D004359:Drug Therapy, Combination; D065130:Endothelin A Receptor Antagonists; D017079:Exercise Tolerance; D006439:Hemodynamics; D006801:Humans; D006976:Hypertension, Pulmonary / Q000145:classification / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D044062:Prostaglandins I / Q000627:therapeutic use; D012307:Risk Factors; D012720:Severity of Illness Index
chemical_list: D065130:Endothelin A Receptor Antagonists; D010975:Platelet Aggregation Inhibitors; D044062:Prostaglandins I